Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
362 studies found for:    Amyotrophic Lateral Sclerosis (ALS)
Show Display Options
RSS Create an RSS feed from your search for:
Amyotrophic Lateral Sclerosis (ALS)
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Device: surgical implantation
2 Completed Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Drug: Basiliximab;   Drug: Methylprednisolone;   Drug: Prednisone;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil
3 Recruiting Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Procedure: Amyotrophic Lateral Sclerosis
4 Active, not recruiting Therapeutic Imaging Biomarkers for Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Procedure: ALS Patients receiving stem cells;   Procedure: ALS patients not receiving stem cells
5 Completed In-situ Cytokines Expression in the CNS in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Other: in-situ cytokine expression
6 Suspended Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Biological: autologous bone marrow-derived stem cells
7 Enrolling by invitation Biological Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Other: Biological: Cell-based therapeutics;   Other: Symptomatic treatment of ALS
8 Completed
Has Results
Efficacy and Tolerability of Tauroursodeoxycholic Acid in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: tauroursodeoxycholic acid (TUDCA);   Drug: Placebo
9 Terminated
Has Results
Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Lithium Carbonate;   Drug: Riluzole;   Drug: placebo
10 Recruiting Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: [18F] GE-180
11 Completed Quantitative Neuromuscular Ultrasonography in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention:
12 Completed Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: SB-509
13 Recruiting The National Amyotrophic Lateral Sclerosis Registry
Condition: Amyotrophic Lateral Sclerosis
Intervention:
14 Completed Amyotrophic Lateral Sclerosis Web Based Patient Care Database: ALSConnection.Org
Condition: Amyotrophic Lateral Sclerosis
Intervention: Behavioral: ALS Registry
15 Not yet recruiting Bioenergetics and Protein Metabolism in Sporadic Amyotrophic Lateral Sclerosis
Condition: Sporadic Amyotrophic Lateral Sclerosis
Intervention: Other: Skin Biopsy
16 Unknown  Far Infrared Irradiation for Control, Management and Treatment of Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Radiation: Far Infrared Radiation (5μm to 20μm wavelength);   Radiation: Far infrared radiation
17 Unknown  Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: Olanzapine
18 Completed
Has Results
Safety and Efficacy Study of Creatine and Tamoxifen in Volunteers With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: creatine;   Drug: tamoxifen
19 Completed Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Drug: MCI-186;   Drug: Placebo;   Drug: MCI-186 in open label phase
20 Withdrawn Magnetic Resonance Imaging (MRI) in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Device: 7 Tesla MRI

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.